Merck EBIT 2010-2025 | MRK

Merck EBIT for the quarter ending March 31, 2025 was $5.937B, a 3.07% increase year-over-year.

  • Merck 2024 EBIT was 20.221B, a 584.53% increase from 2023.
  • Merck 2023 EBIT was 2.954B, a 83.84% decline from 2022.
  • Merck 2022 EBIT was 18.282B, a 38.51% increase from 2021.

EBIT can be defined as earnings before interest and taxes.

Merck EBIT 2010-2025 | MRK

  • Merck 2024 EBIT was 20.221B, a 584.53% increase from 2023.
  • Merck 2023 EBIT was 2.954B, a 83.84% decline from 2022.
  • Merck 2022 EBIT was 18.282B, a 38.51% increase from 2021.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B